# FDA recall D-433-2013

> **Lloyd Inc. of Iowa** · Class II · drug recall initiated 2013-04-01.

## Product

Lloyd Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX.  The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.

## Reason for recall

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

## Distribution

The firm distributed the bulk product to Forest Laboratories, Inc, St. Louis, MO who repackaged the product into 100-tablet bottles and distribution was made to 75 customers Nationwide and Puerto Rico.

## Key facts

- **Recall number:** D-433-2013
- **Recalling firm:** Lloyd Inc. of Iowa
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-04-01
- **Report date:** 2013-05-29
- **Termination date:** 2014-05-08

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Shenandoah, IA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-433-2013

## Citation

> AI Analytics. FDA recall D-433-2013. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-433-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*